Will GE fall behind rivals in bid to dominate healthcare industry?
This article was originally published in Clinica
Executive Summary
After Siemens succeeded in pulling off two IVD acquisitions in the form of Bayer Diagnostics and DPC last year, little surprise that imaging rival GE came up with a deal to match in January when it said it was acquiring Abbott's lab diagnostics and point-of-care businesses for $8.1bn.